Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer
about
Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivitySurvival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression.Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry.Ca2+ Selective Host Rotaxane Is Highly Toxic Against Prostate Cancer Cells.Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)
P2860
Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic Impacts of Metastat ...... ith Metastatic Prostate Cancer
@ast
Prognostic Impacts of Metastat ...... ith Metastatic Prostate Cancer
@en
type
label
Prognostic Impacts of Metastat ...... ith Metastatic Prostate Cancer
@ast
Prognostic Impacts of Metastat ...... ith Metastatic Prostate Cancer
@en
prefLabel
Prognostic Impacts of Metastat ...... ith Metastatic Prostate Cancer
@ast
Prognostic Impacts of Metastat ...... ith Metastatic Prostate Cancer
@en
P2093
P2860
P50
P1476
Prognostic Impacts of Metastat ...... ith Metastatic Prostate Cancer
@en
P2093
Ki Hong Kim
Sang Un Park
Seung Choul Yang
P2860
P304
P356
10.3349/YMJ.2015.56.5.1206
P577
2015-09-01T00:00:00Z